APR 07, 2017 9:56 AM PDT

Atypical Form of Chronic Fatigue Stumps Researchers

WRITTEN BY: Kara Marker

It is uncertain what precisely causes myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), but it is definitely more than just excessive exhaustion. Now in a new study, researchers uncover that the disease is split into two forms, which follow different paths in the body to cause disease.

According to the ME Association, ME/CFS in all forms causes severe fatigue, muscle and joint pain, disordered sleep, gastric disturbances, and poor memory and concentration. While many of the details are unknown concerning this condition’s origin, scientists from Columbia University have identified two distinct forms of ME/CFS that differ based on immune signatures: classical and atypical.

Source: SheKnows

An immune signature consists of specific immune chemicals, often cytokines and chemokines, involved in a certain immune response. Like the immune signatures seen in a Strep throat infection would be different from a case of the flu, the two recently discovered forms of ME/CFS show different levels of immune molecules in the immune response.

These two “types” of ME/CFS also differ based on symptoms that characterize the beginning of the disease. Classical forms of the condition begin with a sudden, flu-like infection, but symptoms in atypical ME/CFS seem to come months or even years after the initial event that “triggers” disease.

Before the present study, researchers studying ME/CFS knew that the disease unfolded in distinct stages, including a major drop in immune molecules after the three-year mark of a person’s disease, making the immune signatures between people in early stages and people in later stages vastly different.

However, in the new study, while researchers saw a similar drop in the levels of immune molecules after the three-year mark, it was only in the study participants with classical ME/CFS; cases of atypical ME/CFS showed immune molecule levels stay the same or even increase after three years.

The study consisted of various immunoassays, biological experiments capable of measuring the immune molecules in a particular immune signature. In total they analyzed 51 immune biomarkers in cerebrospinal fluid samples, 32 cases of classical and 27 cases of atypical ME/CFS

Overall, they saw lower levels of immune molecules in individuals with atypical ME/CFS than those with the classical form of the disease. Specifically, they saw lower levels of a cytokine called interleukin-7 which is linked to viral infections, interleukin-17A, and chemokine (CXC motif) ligand 9 (CXCL9), which is an inflammatory molecule linked to neurological disorders.

Understanding the immunological differences between these two forms of the disease at a molecular level could help doctors understand a patient’s specific disease characteristics immediately following ME/CFS diagnosis as opposed to three years down the line, which could improve treatment options and long-term quality of life.

"Early identification of patients who meet the usual clinical criteria when first diagnosed but then go on to develop atypical features would help clinicians like myself identify and treat these complex cases and even prevent fatal outcomes," explained co-author Daniel L. Peterson, MD.

"Multiple biological pathways are likely involved in the pathogenesis of ME/CFS, with a range of clinical subtypes relating to variability in the types of environmental triggers, genetic and epigenetic vulnerability, as well as comorbidity patterns," said senior author Ian Lipkin, MD. "Shedding light on these pathways may help us to identify the various agents that precipitate disease as well as to design more precise, targeted treatments."

Researchers are still considering many more factors that might play a role in the deviated path taken by cases of atypical ME/CFS compared to the classical form of the disease: genetic susceptibilities, unidentified immune molecules that are involved, and cognitive dysfunction are all being considered.

The present study was published in the journal Translational Psychiatry.

Sources: ME Association, Immunity, Columbia University's Mailman School of Public Health

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 11, 2019
Health & Medicine
SEP 11, 2019
Diagnosis and Treatment of Neurosarcoidosis
Sarcoidosis is a multisystem inflammatory disease characterized by the formation of non-caseating granulomas in the affected organs. The majority of p...
OCT 01, 2019
Infographics
OCT 01, 2019
Do You Know Your Measles Immune Status?
Measles outbreaks continue to make news around the world. The Centers for Disease Control and Prevention update on a weekly basis the number of measles cas...
OCT 25, 2019
Drug Discovery & Development
OCT 25, 2019
Novel Therapeutic For Eradicating The Flu Virus
Public Health officials have long warned about pandemic pathogens flying fast around the world. One virus already spreads across the globe annually leading...
NOV 01, 2019
Immunology
NOV 01, 2019
Immunity to HPV Can Prevent Skin Cancer
Scientists discovered a surprise benefit of low-risk human papillomaviruses (HPV), a typical resident of human skin. New research shows that these harmless...
NOV 29, 2019
Immunology
NOV 29, 2019
Protecting Killer Immune Cells from Themselves
Destroying human cells compromised by viruses and cancer is the name of the game for so-called “killer” cells of the immune system. They employ...
JAN 19, 2020
Immunology
JAN 19, 2020
Overactive Immune Gene May Cause Schizophrenia
A windy road links excessive activity of the “C4” gene to the development of schizophrenia. Researchers begin to study C4 activity as part of n...
Loading Comments...